194 related articles for article (PubMed ID: 37938875)
21. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
22. Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study.
Wirtz AL; Weir BW; Mon SHH; Sirivongrangson P; Chemnasiri T; Dunne EF; Varangrat A; Hickey AC; Decker MR; Baral S; Okanurak K; Sullivan P; Valencia R; Thigpen MC; Holtz TH; Mock PA; Cadwell B; Adeyeye A; Rooney JF; Beyrer C;
JMIR Res Protoc; 2020 Jan; 9(1):e15354. PubMed ID: 32012113
[TBL] [Abstract][Full Text] [Related]
23. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
[TBL] [Abstract][Full Text] [Related]
24. Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial.
Ortblad KF; Bardon AR; Mogere P; Kiptinness C; Gakuo S; Mbaire S; Thomas KK; Mugo NR; Baeten JM; Ngure K
JAMA Netw Open; 2023 Jun; 6(6):e2318590. PubMed ID: 37318803
[TBL] [Abstract][Full Text] [Related]
25. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
[TBL] [Abstract][Full Text] [Related]
26. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
[TBL] [Abstract][Full Text] [Related]
27. Mobile App (UPrEPU) to Monitor Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men: Protocol for a User-Centered Approach to Mobile App Design and Development.
Strong C; Wu HJ; Tseng YC; Yuan CW; Yu YF; Liao JC; Chen YW; Hung YC; Li CW; Huang PH; Ko NY; Ku SW
JMIR Res Protoc; 2020 Dec; 9(12):e20360. PubMed ID: 33258793
[TBL] [Abstract][Full Text] [Related]
28. Integrating Enhanced HIV Pre-exposure Prophylaxis Into a Sexually Transmitted Infection Clinic in Lilongwe: Protocol for a Prospective Cohort Study.
Rutstein SE; Matoga M; Chen JS; Mathiya E; Ndalama B; Nyirenda N; Bonongwe N; Chithambo S; Chagomerana M; Tegha G; Hosseinipour MC; Herce ME; Jere E; Krysiak RG; Hoffman IF
JMIR Res Protoc; 2022 Dec; 11(12):e37395. PubMed ID: 36469400
[TBL] [Abstract][Full Text] [Related]
29. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol.
Jin X; Wang H; Li H; Chu Z; Zhang J; Hu Q; Lv W; Huang X; Chen Y; Wang H; He X; Zhang L; Hu Z; Bao R; Li S; Ding H; Geng W; Jiang Y; Shang H; Xu J;
BMC Public Health; 2020 Jul; 20(1):1160. PubMed ID: 32709230
[TBL] [Abstract][Full Text] [Related]
30. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
[TBL] [Abstract][Full Text] [Related]
31. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
Hoornenborg E; Coyer L; Boyd A; Achterbergh RCA; Schim van der Loeff MF; Bruisten S; de Vries HJC; Koopsen J; van de Laar TJW; Prins M;
J Hepatol; 2020 May; 72(5):855-864. PubMed ID: 31862485
[TBL] [Abstract][Full Text] [Related]
32. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
Swendeman D; Rotheram-Borus MJ; Arnold EM; Fernández MI; Comulada WS; Lee SJ; Ocasio MA; Ishimoto K; Gertsch W; Duan N; Reback CJ; Murphy DA; Lewis KA;
Lancet Digit Health; 2024 Mar; 6(3):e187-e200. PubMed ID: 38395539
[TBL] [Abstract][Full Text] [Related]
33. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
34. HIV Prevention Via Mobile Messaging for Men Who Have Sex With Men (M-Cubed): Protocol for a Randomized Controlled Trial.
Sullivan PS; Zahn RJ; Wiatrek S; Chandler CJ; Hirshfield S; Stephenson R; Bauermeister JA; Chiasson MA; Downing MJ; Gelaude DJ; Siegler AJ; Horvath K; Rogers E; Alas A; Olansky EJ; Saul H; Rosenberg ES; Mansergh G
JMIR Res Protoc; 2019 Nov; 8(11):e16439. PubMed ID: 31730043
[TBL] [Abstract][Full Text] [Related]
35. A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled Trial.
Mogaka JN; Otieno FA; Akim E; Beima-Sofie K; Dettinger J; Gomez L; Marwa M; Odhiambo B; Ngure K; Ronen K; Sharma M; John-Stewart G; Richardson B; Stern J; Unger J; Udren J; Watoyi S; Pintye J; Kinuthia J
JMIR Res Protoc; 2023 Jan; 12():e41170. PubMed ID: 36716092
[TBL] [Abstract][Full Text] [Related]
36. Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial.
MacDonell KK; Wang B; Phanuphak N; Janamnuaysook R; Srimanus P; Rongkavilit C; Naar S
JMIR Res Protoc; 2022 May; 11(5):e37659. PubMed ID: 35587370
[TBL] [Abstract][Full Text] [Related]
37. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
[TBL] [Abstract][Full Text] [Related]
38. HIV and other STIs self-testing to reduce risk compensation among men who have sex with men who use oral pre-exposure prophylaxis in China: protocol for a randomised waitlist-controlled trial.
Zhang J; Huang X; Chen Y; Wang H; Zhang Y; Wang H; Mei Z; Jia Y; Chu Z; Hu QH; He X; Zhang L; Hu Z; Bao R; Li S; Ding H; Jiang Y; Geng W; Tang W; Xu J;
BMJ Open; 2020 Jul; 10(7):e036231. PubMed ID: 32690516
[TBL] [Abstract][Full Text] [Related]
39. Risk-Taking Behaviors and Adherence to HIV Pre-Exposure Prophylaxis in Users of Geosocial Networking Apps: Real-World, Multicenter Study.
Wang H; Zhang J; Chu Z; Hu Q; Dong W; Huang X; Chen Y; Wang H; He X; Zhang L; Hu Z; Bao R; Li S; Li H; Cui S; Jin X; Ding H; Geng W; Jiang Y; Xu J; Shang H
J Med Internet Res; 2020 Oct; 22(10):e22388. PubMed ID: 33052132
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial.
Agustí C; Martínez Riveros H; García-Pérez J; Descalzo V; Fernandez G; Ramírez-Marinero A; Gonzalez MV; Díaz Y; Montoro-Fernandez M; Romano-deGea P; Araujo SG; Muntada E; Casabona J
BMJ Open; 2023 Oct; 13(10):e073459. PubMed ID: 37844988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
